Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation

Eitemau Tebyg

• Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in C3
  gan: Ebun Omoyinmi, et al.
  Cyhoeddwyd: (2018-11-01)
• Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
  gan: Papadopoulou, Charalampia, et al.
  Cyhoeddwyd: (2019)
• Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in C3
  gan: Omoyinmi, Ebun, et al.
  Cyhoeddwyd: (2018)
• Autoinflammation due to homozygous S208 MEFV mutation
  gan: Hong, Ying, et al.
  Cyhoeddwyd: (2019)
• Gene hunting in autoinflammation
  gan: Standing, Ariane, et al.
  Cyhoeddwyd: (2013)